Article info

Download PDFPDF

ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)

Authors

  1. Correspondence to Dr Susana Banerjee, Gynaecology Unit, Royal Marsden NHS Foundation Trust, London, UK; susana.banerjee{at}rmh.nhs.uk
View Full Text

Citation

Banerjee S, Stewart J, Porta N, et al
ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)

Publication history

  • Accepted August 12, 2021
  • First published September 13, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.